key: cord-0838106-nts938t2
authors: Martinez-Murcia, A.; Garcia-Sirera, A.; Navarro, A.; Ros-Tarraga, P.; Perez, L.
title: Current quantitative polymerase chain reaction to detect severe acute respiratory syndrome coronavirus 2 may give positive results for other described coronavirus
date: 2021-02-09
journal: nan
DOI: 10.1101/2021.02.08.21251332
sha: 82586f5ba95f42199c4ee5199038a06df7b5bac1
doc_id: 838106
cord_uid: nts938t2

Some weeks after the first CoVID-19 outbreak, the WHO published some qPCR protocol assays developed by different institutions worldwide. These qPCR designs are being used to detect the presence of SARS-CoV-2 in the population, which allow us to monitore the prevalence of the virus during the pandemic. Moreover, the use of these designs is wide spreading and nowadays they are used to detect SARS-CoV-2 in environmental samples to act as epidemiological surveillance tool. However, at the time of designing the published RT-qPCR assays, a lack of SARS-CoV-2 genomes available may explain a low exclusivity in some cases. In this study, we are reporting experimental data which demonstrate that some of the current qPCR used to detect SARS-CoV-2 may give positive results for other described coronavirus different from SARS-CoV-2.

The Coronavirus Disease 2019 , characterized as a pandemic by the World Health Organization (WHO), is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a Betacoronavirus with similar characteristics than SARS-CoV, Bat SARS-CoV and Pangolin CoV, among others (Ceraolo et al, 2020; Zhou et al., 2020) (WHO, 2020b) . Due to the availability of the oligo sequences and the support from prestigious organizations, these qPCR designs were the basis to develop qPCR methods and many commercial qPCR kits. Most of them are being used by laboratories worldwide to detect the presence of SARS-CoV-2 in human samples, but also from the environment, like wastewater samples. RT-qPCR tests in population are a short-term solution to assess the prevalence of the virus in a determinate date, but setting up feasible and reliable methods for SARS-CoV-2 epidemiological surveillance is necessary to successfully combat this pandemic virus and apply efficient preventive measures in case of virus reappearance. Difficulties of an easy symptom-based diagnosis (particularly at early stages of the infection), the existence of a considerable asymptomatic population, the lack of effective treatment or vaccine, and the widespread nature of the pandemics, have enforced radical and extremely costly epidemiological control measures, including worldwide lockdowns. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 Scientific reports have demonstrated that asymptomatic and recently recovered patients can excrete SARS-CoV-2 in faeces and urine (Cheung et al., 2020; Lescure et al., 2020; Lo et al., 2020; Randazzo et al., 2020a; Sun et al., 2020; Wang et al., 2020) . Also, the fact that SARS-CoV-2 can be transmitted by two ways, directly through respiratory droplets and indirectly through fomites, is accepted because positive results were obtained from samples of various environmental surfaces, air and sewage in hospital and community settings (Mouchtouri et al., 2020; WHO, 2020c) . All these together have generally been taken as support to consider that environmental samples from different places, like those from wastewater, could act as an effective epidemiological surveillance tool. However, when testing SARS-CoV-2 by qPCR in environmental samples, the exclusivity of primers/probe sequences becomes extremely relevant because the diversity of organisms in nature is huge when compared with human clinical samples, where only some selected SARS-CoV-2 clones are expected. In a previous paper, we analysed the in silico exclusivity of some of the most worldwide used qPCR designs published by WHO and our own qPCR design transferred as GPS™ CoVID-19 dtec-RT-qPCR Test and commercially available (Martínez-Murcia et al., 2020) . The analysis showed a relatively low SARS-CoV-2 in silico specificity in several of the qPCR designs, while the qPCR available by GPS™ was the most exclusive by far. However, experimental work supporting above analysis was not available at that time.

In the present study, we empirically demonstrated that some of the currently qPCR used to detect SARS-CoV-2 may give positive results for other described coronavirus. This finding is supported by experimental results of qPCR assays using synthetic sequence templates belonging to a non-SARS-CoV-2 coronavirus.

The primers and probes sequences of the qPCR designs subjected to analysis in the present study (CDC Atlanta, 2020; Corman et al., 2020; Institut Pasteur, 2020; Martínez-Murcia et al., 2020) All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint were used to find similar regions between close biological sequences using the Basic Local Alignment Search Tool (BLAST) software available on the National Center for Biotechnology Information (NCBI, https://blast.ncbi.nlm.nih.gov/Blast.cgi) website databases (Bethesda, MD, USA). The closest coronavirus strain for each one, different from SARS-CoV-2, was selected and used to test their in vitro exclusivity.

In order to test the in vitro exclusivity of the qPCR designs, different synthetic DNA templates provided by IDT (California, USA) and Eurofins Genomics Germany GmbH (Ebersberg, Germany) were used. They were synthetised containing full match sequences, to act as a positive control for each qPCR design, and the corresponding target sequence of the selected Pangolin CoV strain. A non-related target control sequence was added to synthetic templates to calibrate template copy number. Primers and probes of IP2 and IP4 designs were provided by IDT (California, USA), and these of RdRp-P2, N1 and N2 were obtained from Eurofins Genomics Germany GmbH (Ebersberg, Germany). Finally, GPS™ CoVID-19 dtec-RT-qPCR Test was supplied by Genetic Analysis Strategies SL (Alicante, Spain). Synthetic templates were diluted by preparing 10-fold dilution series containing 10 to 10 6 copies of synthetic templates. qPCR tests, were performed following the recommended protocols by the corresponding research institute, using the GPS™ LyoMix RT-qPCR (Alicante, Spain). As recommended for each qPCR design, we used an amplification step of 50 cycles at 95ºC for 15 s and at 58ºC for 30 s for IP2 and IP4 (Institut Pasteur, 2020); 45 cycles at 94ºC for 15 s and at 58ºC for 30 s for RdRp-P2 ; and 45 cycles at 95ºC for 3s and at 55ºC for 30 s for N1 and N2 (CDC Atlanta, 2020). Finally, the GPS™ CoVID-19 dtec-RT-qPCR Test was subjected to qPCR following the manufacturer's instructions (Martínez-Murcia et al., 2020) .

Reverse transcription and activation steps were performed, according to the LyoMix RT-qPCR used, at 50ºC for 10 min and 95ºC for 1 min. Positive and negative PCR controls were included, and reaction mixtures were subjected to qPCR in a StepOne thermocycler (Applied Biosystems, USA). All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint

The alignments performed between primers and probes sequences of the qPCR designs published by the WHO and the GPS™ qPCR kit, showed that Pangolin CoV isolate MP789, complete genome (Genbank No.: MT121216.1) was the closest virus sequence for IP4 and N1 qPCR designs; and Bat coronavirus RaTG13, complete genome (Genbank No.: MN996532.1) for IP2, N2, E, RdRp-P2 and GPS™ kit. RaTG13 is a single Bat-CoV sequence which shows the highest homology (96.7%) with all the SARS-CoV-2 sequences, and it was deposited the 27 th January, much after the outbreak started. Therefore, the possibility of RNA contamination during genome sequencing should be ruled-out before taking further conclusions (Martínez-Murcia et al., 2020) . perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint MT121216.1; d) N2 with Pangolin CoV -MT072864.1; e) RdRp-P2 with Pangolin CoV -

with Pangolin CoV -EPI_ISL_410539.

As illustrated in the alignment of the qPCR designs (primers and probes) and their closest Pangolin CoV sequences (Fig. 1) , both IP2 and IP4 showed 4 mismatches, 2 located in probe and 2 in reverse primer; N1 showed 2 mismatches, 1 in each primer; N2 showed 4 mismatches, 1 in forward primer and 3 in probe; RdRp-P2 showed 3 mismatches, 1 in each primer and 1 in probe; E showed full matching; and finally GPS™ CoVID-19 dtec-RT-qPCR Test showed a total of 21 mismatches, with the highest number of them located in reverse primer. According to these, we considered the possibility that IP2, IP4, N1, E and RdRp-P2 may amplify samples which would contain strains of selected Pangolin CoV, or other non-described viral strains with similar sequences. Therefore, to ascertain this prediction based on the in silico analysis with an in vitro test, was the purpose of this study. As the E qPCR design showed full matching with the selected coronavirus sequence, its corresponding in vitro test was excluded from this analysis.

Nevertheless, the qPCR designed for gene E was conceived to be inclusive for virus of the subgenus Sarbecovirus .

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint Experimental work to test the in vitro exclusivity of all these qPCR designs was carried out by testing each template (10 to 10 6 copies) of the Pangolin CoV selected sequences, and results are shown in Figure 2 . Positive controls for all qPCR tests were also performed by using synthetic templates (10 to 10 6 copies) with sequences showing full-matching to the corresponding qPCR design, and they all gave exponential amplification (Fig. 2) . The results indicated that IP2, N1 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint and RdRp-P2 qPCR designs were able to amplify the nucleotide sequence of the selected Pangolin CoV strains, which validates the hypothesis of possible false positives when testing exclusively for SARS-CoV-2. In the cases of N1 and RdRp-P2 (with 2 and 3 mismatches, respectively), Ct values obtained were very close to this of the corresponding positive controls, which suggests a hybridization relatively stable of oligonucleotide primers and probes with target sequences.

However, the IP2 qPCR design, showing 4 mismatches, yielded Ct values considerably delayed from these of the positive control; thus, it seems this amplification, although it occurred, was much weaker. IP4 and N2, both showing 4 mismatches, showed no qPCR amplification at all; so, in these two cases, mismatching seems to be more efficient discriminating closely related sequences. The experiments were repeated 3 times and results were reproducible in all cases. Endpoint PCR was assessed with primers of IP4 and N2 (excluding the corresponding probes) and very robust bands of the expected fragment-size were obtained in the agarose gels (not shown).

This finding suggests that amplification may occur in the qPCR, but the discriminative character may reside in the probe (2 and 3 mismatches, respectively). As expected, the GPS™ kit showed no amplification when tested against the most similar described sequence (21 mismatches). It should be noted that the GPS™ kit design undergoes continuous revision to ensure its full specificity with respect to all the variants that are emerging as a consequence of the high mutation rate of the SARS-CoV-2.

These results demonstrate that some qPCR designs may be able to detect SARS-CoV-2-related coronavirus, such these from Pangolin CoV strains, and maybe similar Sarbecovirus nondescribed yet. This finding may do not have relevance on human diagnostics for clinical specimens, as currently, animal-specific coronavirus should not be frequently found in human samples. Additionally, the most common human coronavirus strains which cause breathing illnesses, like OC43, HKU1, NL63 and 229E, show a low homology with SARS-CoV-2 (Zhou et al., 2020). However, the exclusivity of the qPCR design is particularly relevant for SARS-CoV-2 monitoring in environmental samples, for instance in the epidemiological surveillance of wastewaters. Several laboratories have developed protocols for analysis of water samples by using All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint some of these published qPCR designs to detect SARS-CoV-2 (Chavarria-Miró et al., 2020; Fongaro et al., 2020; Randazzo et al., 2020b) , evaluated in the present study. Some of their results, although with a very low signal, suggest the presence of SARS-CoV-2 in wastewater samples harvested in countries remotely distant from China, much time before (12 th March 2019 and 27 th November 2019) the first outbreak was formally detected (31 th December 2019). Above finding was supported by very low qPCR signals (Ct values ranging 39-40, Chavarria-Miró et al., 2020) .

Having ruled-out a possible cross contamination of PCR reactions, some of these weak-positives may be explained by the consequences recruited in this work. They may come from other highly similar coronavirus sequences, rather than SARS-CoV-2.

Considering the current knowledge about the huge extent of microbial diversity still to be described (number of cultured/described species have been estimated to represent ca. 4 -5% from this existing in nature), it is crucial to take into account that environmental samples may contain a pool of many different but closely related viruses, consequently a considerable number of different sequences were unknown at the time of qPCR design. The use of highly exclusive primers and probes to detect only the SARS-CoV-2 causing CoVID-19 may help on the purpose but, definitely, studies to discriminate this from the real diversity should be complemented by using massive sequencing techniques, like next-generation sequencing (NGS).

The authors confirm that the ethical policies of the journal, as noted on the journal's author guidelines page, have been adhered to. No ethical approval was required.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint

2019-Novel Coronavirus (2019-nCoV) Real-time RT-PCR Panel Primers and Probes

Genomic variance of the 2019-nCoV coronavirus

Sentinel surveillance of SARS-CoV-2 in wastewater anticipates the occurrence of COVID-19 cases

Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a

Systematic review and meta-analysis

Detection of 2019 novel coronavirus (2019-nCV) by real-time RT-PCR

SARS-CoV-2 in human sewage in Santa Catalina, Brazil

Protocol: Real-time RT-PCR assays for the detection of SARS-CoV-2

Clinical and virological data of the first cases of COVID-19 in Europe: a case series

Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?

Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau

Comparative in silico design and validation of GPS™ CoVID-19 dtec-RT-qPCR Test

Environmental contamination of SARS-CoV-2 on surfaces, airconditioner and ventilation systems

Metropolitan wastewater analysis for COVID-19 epidemiological surveillance

SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area

Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient

Detection of SARS-CoV-2 in different types of clinical specimens

RdRp-P2 Pangolin CoV -MT121216.1 15290 -15389 bp 100 bp E Pangolin CoV -MT121216.1 26103 -26215 bp 113 bp CDC Atlanta

Pangolin CoV -MT121216.1 28073 -28144 bp 72 bp N2 Pangolin CoV -MT072864.1 29102 -29166 bp 65 bp

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in 

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted February 9, 2021. ; https://doi.org/10.1101/2021.02.08.21251332 doi: medRxiv preprint